Skip to content

A Study to Determine the Feasibility of Wireless Electrocardiography

Study to Determine the Feasibility of Wireless Electrocardiography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02162394
Enrollment
14
Registered
2014-06-12
Start date
2014-06-30
Completion date
2016-01-31
Last updated
2017-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Conduction Defects, Normal Sinus Rhythm, Premature Atrial and Ventricular Beats

Brief summary

The investigators are conducting a prospective, observational study to examine the ECG waveforms captured by the new medical device as compared to a traditional Holter monitor for subsequent use in visual diagnoses of atrial and ventricular arrhythmias as well as cardiac impulse and/or conduction disorders by qualified clinicians. The hypothesis is that this new medical device prototype is non-inferior to traditional Holter monitoring for capturing ECG waveforms that can be visually assessed for atrial and ventricular arrhythmias as well as disorders of cardiac impulse formation and/or conduction.

Interventions

DEVICEObservational ambulatory ECG monitoring

Sponsors

Peerbridge Health, Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be at least 18 years of age * Patients must have a medical indication to wear a Holter monitor * Patients must not be pregnant * Patients must be able to comply with the study procedures * Patients must be willing to participate and able to provide informed consent * Patients must be willing to wear both devices (Holter and the wireless device prototype) simultaneously and continuously for a 2 to 3 hr period

Exclusion criteria

* Patients who are not able or willing to comply with study procedures * Patients with an existing implanted cardioverter-defibrillator and/or pacemaker * Patients with a known life threatening arrhythmia * Patients who manifest low voltage on their electrocardiogram * Patients affected by inflammatory and/or infectious skin disorders

Design outcomes

Primary

MeasureTime frame
Percent of 8 second ECG strips of sufficient quality for visual diagnosis3 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026